688050 Stock Overview
Eyebright Medical Technology (Beijing) Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 1/6 |
My Notes
Capture your thoughts, links and company narrative
Eyebright Medical Technology (Beijing) Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥88.34 |
| 52 Week High | CN¥118.00 |
| 52 Week Low | CN¥65.17 |
| Beta | 0.53 |
| 1 Month Change | -4.05% |
| 3 Month Change | 19.31% |
| 1 Year Change | -6.19% |
| 3 Year Change | -25.69% |
| 5 Year Change | n/a |
| Change since IPO | -33.88% |
Recent News & Updates
We Think That There Are Some Issues For Eyebright Medical Technology (Beijing) (SHSE:688050) Beyond Its Promising Earnings
Nov 06
Returns At Eyebright Medical Technology (Beijing) (SHSE:688050) Are On The Way Up
Oct 18Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Oct 01Recent updates
We Think That There Are Some Issues For Eyebright Medical Technology (Beijing) (SHSE:688050) Beyond Its Promising Earnings
Nov 06Returns At Eyebright Medical Technology (Beijing) (SHSE:688050) Are On The Way Up
Oct 18Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) Stocks Shoot Up 26% But Its P/E Still Looks Reasonable
Oct 01Eyebright Medical Technology (Beijing) Co., Ltd. Just Missed Earnings - But Analysts Have Updated Their Models
Aug 23Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)
Jul 15Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings
Jun 10Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?
May 13Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues
Apr 24Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think
Apr 21Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Mar 25A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)
Mar 18Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)
Mar 01Shareholder Returns
| 688050 | CN Medical Equipment | CN Market | |
|---|---|---|---|
| 7D | -7.3% | -2.8% | -1.2% |
| 1Y | -6.2% | -9.2% | 11.8% |
Return vs Industry: 688050 exceeded the CN Medical Equipment industry which returned -9.2% over the past year.
Return vs Market: 688050 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 688050 volatility | |
|---|---|
| 688050 Average Weekly Movement | 10.1% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 688050 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 688050's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 2,091 | Jiangbing Xie | www.ebmedical.com |
Eyebright Medical Technology (Beijing) Co., Ltd. develops a range of ophthalmic medical products. Its products include surgical implants and instruments, equipment, optometric lenses, eye drops, etc. for the treatment of ophthalmic diseases and vision problems, such as cataract, glaucoma, refractive errors, and other ophthalmic diseases.
Eyebright Medical Technology (Beijing) Co., Ltd. Fundamentals Summary
| 688050 fundamental statistics | |
|---|---|
| Market cap | CN¥16.74b |
| Earnings (TTM) | CN¥369.60m |
| Revenue (TTM) | CN¥1.36b |
45.3x
P/E Ratio12.3x
P/S RatioIs 688050 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688050 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.36b |
| Cost of Revenue | CN¥451.64m |
| Gross Profit | CN¥906.70m |
| Other Expenses | CN¥537.10m |
| Earnings | CN¥369.60m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.95 |
| Gross Margin | 66.75% |
| Net Profit Margin | 27.21% |
| Debt/Equity Ratio | 24.2% |
How did 688050 perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield14%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 22:54 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Eyebright Medical Technology (Beijing) Co., Ltd. is covered by 11 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jian Jun Zou | Chasing Securities |
| Jin Zhang | China International Capital Corporation Limited |
| Yichi Zhang | China International Capital Corporation Limited |